GO
Loading...

Pfizer Prevails in Patent Suit Against Teva

Pfizer said on Tuesday that a U.S. federal court upheld the three main patents covering its Celebrex painkiller, winning a challenge by generic drugmaker Teva Pharmaceutical Industries.

The decision bars Teva from launching a competitor drug in the U.S. until December 2015, Pfizer said.

Don't Miss

U.S. Video